Page last updated: 2024-08-23

acetylshikonin and Granulocytic Leukemia, Chronic

acetylshikonin has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, S; Fan, C; Hao, G; Jiang, H; Qiu, Y; Sun, L; Wu, M; Yang, Z; Yu, L; Zhai, J; Zhang, Y	1

Other Studies

1 other study(ies) available for acetylshikonin and Granulocytic Leukemia, Chronic

Article	Year
Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 122 Topics: Animals; Anthraquinones; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Line; Cell Proliferation; Chlorocebus aethiops; Fusion Proteins, bcr-abl; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Signal Transduction; Vero Cells	2020

Article

Year

Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 122

Topics: Animals; Anthraquinones; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Line; Cell Proliferation; Chlorocebus aethiops; Fusion Proteins, bcr-abl; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Signal Transduction; Vero Cells

2020